As CEO at GMI, Anne is responsible for leading the development and execution of the our long-term strategy and value of the company. Anne oversees the day-to-day management decisions and is the direct liaison to the Board and Directors.
A native ofTipperary, Anne brings over 25 years' experience working in the life science, chemical analysis and diagnostics arenas, in Ireland, the UK and the USA to her role at GMI.
Prior to joining GMI, she was VP and General Manager for Pall Corporations Lab, Food & Beverage business at US-based Danaher Corp. She also held senior roles in strategy development and planning at Agilent Technologies where she led business development and M&A activities for Agilent's $2.3B Life Sciences and Applied Markets division. She also worked with Amersham Biosciences in the UK and GE Healthcare Life Sciences in the UK and USA.
Anne is a graduate of National University of Ireland, Galway, in Microbiology and Molecular Biology and she completed her PhD at Cancer Research UK.